FRANKLIN, Tenn., March 07, 2024 (GLOBE NEWSWIRE) -- Today Clover Health ("Clover" or "the Company") announced Clay Thornton as the newly appointed Chief Financial Officer of its Medicare Advantage (MA) division. Thornton, with an impressive track record spanning over a decade of healthcare financial management and operational leadership, joins as the Company enters the next phase of its lifecycle, targeting Adjusted EBITDA profitability for the full-year 20241, while emphasizing a differentiated PPO-first p ...

FRANKLIN, Tenn., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover" or the "Company") announced today that effective February 16, 2024, the Talent and Compensation Committee of the Company's Board of Directors granted a restricted stock unit award (the "RSUs") to a newly hired employee. The RSUs were granted under the Company's 2022 Inducement Award Plan (the "Inducement Plan") and otherwise will be subject to the terms and conditions of restricted stock unit award ag ...

In the volatile space of penny stocks, three companies are emerging as powerhouses with breakout potential, poised for massive gains. To begin with, the first one’s organic growth, the second one’s data licensing prowess in liquor retail, and the third one’s strategic insurance advancements are captivating the market. Also, the first one leads the veterinary diagnostic space with a diverse product range; the second leverages proprietary data for liquor retail dominance; and the third thrives in the insuranc ...

FRANKLIN, Tenn., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, announced today that it is targeting Adjusted EBITDA profitability for the full-year 2024. (1) "I believe that we are at a critical inflection point in the trajectory of our business. Throughout 2023 our results, driven by strong Insurance performance, have prove ...

FRANKLIN, Tenn., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today released research demonstrating Clover Assistant's impact on medication adherence. The paper, Clover Assistant Use and Medication Adherence for Common Chronic Conditions, examines the correlation between Primary Care Physician (PCP) use of Clover Assistant ...

The past three years of health crisis have led to exponential growth in the Medical Info Systems industry, thanks to the growing demand for contactless services. In the post-pandemic era, the popularity of remote healthcare and a paperless environment have increased further. In fact, in 2023, this industry witnessed massive adoption of artificial intelligence (AI) and the Internet of Medical Things in the form of digital healthcare options in hospitals and other healthcare settings. Apart from being used fo ...

FRANKLIN, Tenn., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover" or the "Company") a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that Scott J. Leffler, its Chief Financial Officer, will be leaving the Company on January 26, 2024 in order to pursue another professional opportunity. Mr. Leffler noted to the Company that his departure does not reflect any disagreement with the Company on any ma ...

Company Participants Andrew Toy - CEO Conference Call Participants John Pinney - Canaccord Genuity Ladies and gentlemen, good afternoon, and welcome to the Clover Health Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the prepared remarks. [Operator Instructions]. As a reminder, today's call is being recorded. Ryan Schmidt You can find today's press release and the accompanying supplemental slides in the Investo ...

8 1 2 | --- | --- | --- | --- | --- | |--------------------------------------------------------|-------|-----------------------------------|-------|-----------------| | Net loss: | S | September 30, \n2023 \n(41,469) S | | 2022 \n(75,489) | | Adjustments | | | | | | Interest expense | | l | | 404 | | Amortization of notes and securities discount | | 一 | | | | Depreciation and amortization | | 557 | | 616 | | Gain on investment | | 一 | | 980 | | Stock-based compensation expense | | 33,070 | | 42,641 | | Prem ...

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS • our expectations regarding results of operations, financial condition, and cash flows; • our expectations regarding the development and management of our Insurance and Non-Insurance businesses; • our ability to successfully enter new service markets and manage our operations; • anticipated trends and challenges in our business and in the markets in which we operate; • our ability to effectively manage our beneficiary base and provider network; • our abi ...